 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

VANCOUVER, British Columbia, April 04, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will...

Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference

This is a signal that XENE's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...

Xenon Pharmaceuticals (XENE, $42.15) Stochastic Oscillator left the oversold zone on April 01, 2024

Xenon Pharmaceuticals Inc. (NASDAQ:XENE  Get Free Report) was the target of some unusual options trading on Wednesday. Stock investors bought 4,063 put options on the stock. This represents an...

Xenon Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:XENE)

Xenon Pharmaceuticals (XENE, $43.52) Stochastic Oscillator left the oversold zone on March 21, 2024

This is a signal that XENE's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

Xenon Pharmaceuticals (XENE, $44.35) RSI Indicator left the oversold zone on March 19, 2024

Xenon Pharmaceuticals (XENE, $42.84) RSI Indicator left the oversold zone on March 18, 2024

Xenon Pharmaceuticals (XENE, $43.9) RSI Indicator left the oversold zone on March 15, 2024

Xenon Pharmaceuticals (XENE, $43.67) RSI Indicator left the oversold zone on March 14, 2024

Xenon Pharmaceuticals (XENE, $45.04) RSI Indicator left the oversold zone on March 13, 2024

VANCOUVER, British Columbia, March 12, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will...

Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days

Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.

Volume (M)	362,875.00
52-Wk High	$50.99
52-Wk Low	$27.99

XENE Xenon Pharmaceuticals Inc

About

Feed

News

Sentiment

Earnings

Fundamentals